Skip to main content
Clinical Trials/NCT02886429
NCT02886429
Completed
Phase 2

Safety and Efficacy of Ultrasound Guided Paravertebral Dexmedetomidine for Postoperative Pain Relief in Video Assisted Thoracoscopy Surgery

Assiut University1 site in 1 country60 target enrollmentAugust 2016

Overview

Phase
Phase 2
Intervention
Bupivacaine
Conditions
Pain, Postoperative
Sponsor
Assiut University
Enrollment
60
Locations
1
Primary Endpoint
post-thoracotomy pain
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Postoperative pain is the most undesired consequence of surgery, and if not managed adequately, can lead to delayed recovery and increased hospital stay. Surveys continue to reveal that postoperative pain is insufficiently managed throughout the first world, let alone in the Third World. An American survey over 20 years showed that only one in four patients had adequate relief of postoperative pain. This has led recovery room protocols to include pain as a fifth vital sign that needs to be addressed before patients are discharged to the ward

Detailed Description

This prospective, randomized, double-blinded, parallel assignment clinical trial will be done after receiving approval from the local ethics committee of the Faculty of Medicine, Assiut University. A written informed consent will be taken after discussing a detailed description of the study with the patients. Patients will be allocated randomly into two equal groups by computer programs and will be contained in sealed opaque envelopes. Patients will be premedicated with midazolam (0.1mg/kg), 30 min before the operation. Patients will be monitored with ECG, non-invasive blood pressure, heart rate, temperature, oxygen saturation, exhaled CO2 (end tidal capnography), and train of four. In both groups, general anesthesia will be induced with propofol (2mg/kg) and fentanyl (1 mcg/kg). Tracheal intubation will be facilitated with cisatracurium 0.1 mg/kg. Anesthesia will be maintained with isoflurane (1-2 %) and cisatracurium (0.05 mg/kg per dose). Fentanyl (0.5mcg/kg) will be repeated if heart rate (HR) and/or mean arterial pressure (MAP) rise 20 % above baseline values. After the end of anesthesia induction and before surgical procedure Technique of ultrasound guided paravertebral block will be done in both groups.

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
October 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sayed Kaoud Abd-Elshafy

Associate profossor of anesthesia

Assiut University

Eligibility Criteria

Inclusion Criteria

  • ASA I, II and III.
  • In the age ranged between 18 up to 60 years.
  • Elective video-assisted thoracoscopy

Exclusion Criteria

  • ASA IV and V
  • Liver impairment
  • Renal impairment
  • allergy to the drugs used
  • Known contraindication for regional techniques such as:
  • Infection near the site of the needle insertion
  • Coagulopathy
  • Anti-coagulation therapy,

Arms & Interventions

Group A

Ultrasound guided paravertebral block with bupivacaine group Thirty patients will be given isobaric bupivacaine 0.5% (0.3ml/kg) via paravertebral route.

Intervention: Bupivacaine

Group B

Ultrasound guided paravertebral block with bupivacaine and dexmedetomidine group Thirty patients will be given isobaric bupivacaine 0.5% (0.3ml/kg) and dexmedetomidine (1 mcg/kg) via paravertebral route (Bupivacaine plus Dexmedetomidine)

Intervention: Bupivacaine

Group B

Ultrasound guided paravertebral block with bupivacaine and dexmedetomidine group Thirty patients will be given isobaric bupivacaine 0.5% (0.3ml/kg) and dexmedetomidine (1 mcg/kg) via paravertebral route (Bupivacaine plus Dexmedetomidine)

Intervention: Dexmedetomidine

Outcomes

Primary Outcomes

post-thoracotomy pain

Time Frame: within first 24 hours after Video Assisted Thoracoscopy Surgery

5. Pain scores at rest and on coughing will be recorded using visual analogue scale (VAS) pain intensities at rest and during coughing/movement assessed by VAS score. The quality of effective analgesia will be expressed as VAS values derived from the VAS pain score, at rest and during coughing during each assessment period (2 h, at 4, 8 and 24 h).

Secondary Outcomes

  • rescue analgesia(within first 24 hours after Video Assisted Thoracoscopy Surgery)
  • nausea, vomiting(within first 24 hours after Video Assisted Thoracoscopy Surgery)
  • sedation score(within first 24 hours after Video Assisted Thoracoscopy Surgery)
  • pulmonary function tests(within first 24 hours after Video Assisted Thoracoscopy Surgery)

Study Sites (1)

Loading locations...

Similar Trials